AI-generated summary
The authors analyzed records of 751 head and neck cancer patients treated at one hospital between 2000 and 2016 and compared median survival with and without photobiomodulation therapy. They report that PBMT was associated with longer median survival, and that more sessions corresponded with better survival. The study was a retrospective record analysis, so the authors state that further research is needed to examine possible synergistic effects with cancer treatments.
- Participants
- 751
- Who or what was studied
- Patients with head and neck cancer treated at Hospital de Caridade Sao Vicente de Paulo, 2000 to 2016
- Limits stated in the abstract
- The abstract describes a retrospective analysis of records from a single hospital and one operator, and it states that further research is needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Oral mucositis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.